QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ZTS

QT65Zoetis Inc.
NYSE·Healthcare·Drug Manufacturers - General·USA
Latest market price
78.71
+1.45+1.88%
OverviewShort InterestFilings
ZTSQT65Zoetis Inc.·NYSE
OverviewShort InterestFilings
78.71+1.88%
TA
Loading chart...
Screen all →
LLY-1.21%$1098.57JNJ-2.48%$228.39ABBV-2.08%$216.63NVS-2.52%$147.08MRK-1.36%$113.87AZN-1.66%$174.93NVO-0.76%$43.19AMGN-1.19%$337.60
Snapshot
IndexS&P 500P/E12.34EPS (ttm)
6.03
Insider Own0.16%
Shs Outstand419.23M
Perf Week-3.30%
Market Cap32.39BForward P/E10.64EPS next Y7.40Insider Trans0.04%Shs Float450.70MPerf Month-0.27%
Enterprise Value39.69BPEG1.50EPS next Q1.85Inst Own80.63%Short Float3.66%Perf Quarter-32.14%
Income2.62BP/S3.41EPS this Y14.57%Inst Trans-Short Ratio4.61Perf Half Y-36.13%
Sales9.51BP/B10.09EPS next Y7.10%ROA17.44%Short Interest16.50MPerf YTD-37.44%
Book/sh7.71P/C12.00EPS next 5Y8.03%ROE62.41%52W High161.76 -51.34%Perf Year-51.31%
Cash/sh4.63P/FCF15.17EPS past 3/5Y-ROIC21.79%52W Low72.38 8.75%Perf 3Y-
Dividend Est.2.12 (2.69%)EV/EBITDA9.85Sales past 3/5Y5.42% 7.24%Gross Margin70.75%Volatility2.31% 2.30%Perf 5Y-
Dividend TTM2.06 (2.62%)EV/Sales4.17EPS Y/Y TTM18.28%Oper. Margin37.57%ATR (14)2.94Perf 10Y-
Dividend Ex-DateJul 20, 2026Quick Ratio1.91Sales Y/Y TTM2.73%Profit Margin27.79%RSI (14)38.13Recom2.56
Dividend Gr. 3/5Y15.44% 20.11%Current Ratio3.15EPS Q/Q3.38%SMA20-0.75%Beta0.77Target Price120.80
Payout33.64%Debt/Eq2.86Sales Q/Q1.89%SMA50-16.56%Rel Volume2.37Prev Close77.26
Employees13,800LT Debt/Eq2.83EarningsAug 04SMA200-34.80%Avg Volume7.07MPrice78.71
IPO DateFeb 01, 2013Option/ShortYes / YesEPS/Sales Surpr.-4.37% -1.69%Net Debt/EBITDA1.81Volume16,741,404Change1.88%
Analyst Ratings
DateActionAnalystRatingTarget
May-27-26DowngradeArgus ResearchBuy → Hold
May-22-26ReiteratedStifel NicolausBuy$105 → $95
May-15-26ReiteratedMorgan StanleyOverweight$160 → $115
May-08-26ReiteratedStifel NicolausBuy$130 → $105
May-08-26ReiteratedUBSNeutral$130 → $99
Apr-28-26ReiteratedUBSNeutral$136 → $130
Feb-26-26ReiteratedBTIGBuy$160
Jan-29-26ReiteratedUBSNeutral$141 → $136
Jan-22-26DowngradePiper SandlerOverweight → Neutral$215 → $135
Dec-18-25ReiteratedMorgan StanleyOverweight$175 → $160
Latest News
Jun-18-26
Jun-18-2610:15PM
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth KnowingYahoo
11:10AM
ZOETIS INC (NYSE:ZTS) Shows Strong Value Potential with Attractive Valuation and High ProfitabilityChartMill
Jun-17-26
Jun-17-2602:16PM
What Makes Zoetis (ZTS) an Attractive Bet?Yahoo
11:24AM
3 S&P 500 Stocks Worth Your AttentionYahoo
Jun-15-26
Jun-15-2606:38PM
If You’re Looking for the ‘Next Big Thing’ Before the OpenAI and Anthropic IPOs, Try This Barchart Stock ScreenerYahoo
12:52PM
Should You Continue to Hold PAHC Stock in Your Portfolio?Yahoo
Jun-12-26
Jun-12-2610:15PM
Zoetis (ZTS) Stock Dips While Market Gains: Key FactsYahoo
04:15PM
Zoetis (ZTS) Stock Draws Fresh Price Target Split After Difficult Q1 UpdateYahoo
12:27PM
PAHC Stock: What's Driving Phibro's Animal Health GrowthYahoo
Jun-11-26
Jun-11-2612:53PM
Is PAHC Undervalued at 10x Earnings vs Peers?Yahoo
12:53PM
Is PAHC Undervalued at 10x Earnings vs Peers?Yahoo
12:10PM
Zoetis Inc (NYSE:ZTS) Offers a Winning Combination of Dividend Growth and Strong FundamentalsChartMill
12:10PM
Zoetis Inc (NYSE:ZTS) Offers a Winning Combination of Dividend Growth and Strong FundamentalsChartMill
12:48AM
Zoetis Might Be Cheap For A ReasonSeekingAlpha
12:48AM
Zoetis Might Be Cheap For A ReasonSeekingAlpha
Company
Ownership
Total institutional ownership80.63%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue9,5099,4679,256
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A2,7812,7942,860
Gross Profit6,7286,6736,396
Selling, General and Administrative Excl. Other2,4032,3782,318
Research and Development721698686
Other Operating Expense3100
Operating Income3,5733,5973,392
Interest Expense241243242
Unusual Expense
———
Non-Operating Income (Expense)301517
Net Income Before Taxes3,3083,3603,133
Income Taxes665687637
Consolidated Net Income2,6432,6732,486
Net Income From Continuing Operations2,6432,6732,496
Net Income2,6432,6732,486
EPS (Recurring)6.046.035.47
EPS (Basic, Before Extraordinaries)6.046.035.47
EPS (Diluted)6.036.025.47
EBITDA4,0304,0693,872
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio13.0520.90—
Price To Sales Ratio3.495.89—
Gross Margin70.7570.4969.10
Operating Margin37.5738.0036.65
Net Margin27.7928.2326.86
Shares Outstanding422443454
Market Capitalization33,21655,738—
Operating Lease Expense
———
Insider Trading Volume
$81.71$75.67$69.64$63.60$57.56● Close Price0.00M0.64M1.27M1.91M2.54MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Stetter MarkDirectorMay 21 '26Option Exercise0.003,14401,572May 26 12:00 AM
PARENT LOUISE MDirectorMay 20 '26Option Exercise0.0024,261028,394May 21 12:00 AM
Bisaro PaulDirectorMay 13 '26Buy75.882,000151,75027,862May 13 12:00 AM
DAMELIO FRANK ADirectorMay 13 '26Buy75.396,650501,34421,458May 13 12:00 AM
MCCALLISTER MICHAEL BDirectorMay 11 '26Buy77.763,000233,27324,524May 12 12:00 AM
Esch KevinExecutive Vice PresidentApr 30 '26Option Exercise0.005190653May 01 12:00 AM
Sarbaugh KeithExecutive Vice PresidentMar 31 '26Option Exercise0.003,05603,870Apr 01 12:00 AM
Sarbaugh KeithExecutive Vice PresidentFeb 19 '26Option Exercise0.0077302,496Feb 23 12:00 AM
Driscoll RimmaExecutive Vice PresidentFeb 19 '26Option Exercise0.0090905,894Feb 23 12:00 AM
Ferran Astorga JeannetteExecutive Vice PresidentFeb 19 '26Option Exercise0.0086301,874Feb 23 12:00 AM
Sanjay KhoslaDirectorFeb 19 '26Option Exercise0.001,61900Feb 23 12:00 AM
Leatherberry Antoinette ReneeDirectorFeb 19 '26Option Exercise0.003,23805,686Feb 23 12:00 AM
Bisaro PaulDirectorFeb 19 '26Option Exercise0.003,238025,862Feb 23 12:00 AM
DAMELIO FRANK ADirectorFeb 19 '26Option Exercise0.001,61900Feb 23 12:00 AM
PARENT LOUISE MDirectorFeb 19 '26Option Exercise0.003,238016,879Feb 23 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR